Clinical Trials Sponsored by San Diego Pacific Oncology & Hematology Associates

Total 5 results

San Diego Pacific Oncology & Hematology Associates

Unknown

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Melanoma (Skin)

United States
San Diego Pacific Oncology & Hematology Associates

Unknown

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Intraocular Melanoma

United States
San Diego Pacific Oncology & Hematology Associates

Unknown

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Melanoma (Skin)

United States
San Diego Pacific Oncology & Hematology Associates

Unknown

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Brain and Central Nervous System Tumors

United States
Foundation Medicine
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; University... and other collaborators

Completed

Concordance Between ctDNA Assay and FoundationOne

Neoplasms | Cancer | Circulating Tumor DNA | Genomic Testing | Genomic Alterations

United States

3

Subscribe